The future of rotavirus vaccines: A major setback leads to new opportunities

Lancet

Volumn 363, Issue 9420, 2004, Pages 1547-1550

  Glass, Roger I ^a,b   Bresee, Joseph S ^a   Parashar, Umesh D ^a   Jiang, Baoming ^a   Gentsch, Jon ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MEASLES MUMPS VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; ROTAVIRUS VACCINE;

AGE DISTRIBUTION; CHILD; CLINICAL TRIAL; DEVELOPED COUNTRY; DIARRHEA; DRUG COST; DRUG INDUSTRY; DRUG SCREENING; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INTUSSUSCEPTION; LEARNING; LICENSING; MEDICAL PRACTICE; PEDIATRICS; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SIDE EFFECT; UNITED STATES; VACCINATION; VIRUS INFECTION;

EID: 2342486044     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16155-2     Document Type: Note

References (25)

1. Centers for Disease Control and Prevention. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 48:1999;1-20
2. American Academy of Pediatrics. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics. 102:1998;1483-1491
3. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine, United States, 1998-1999. MMWR Morb Mortal Wkly Rep. 48:1999;577-581
4. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep. 48:1999;1007
5. Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA. 279:1998;1371-1376
6. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 9:2003;565-572
7. Andrews N, Miller E, Waight P, et al. Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three self-controlled cases series studies in the United Kingdom. Eur J Epidemiol. 17:2001;701-706
8. Sardinas MA, Cardenas AZ, Marie GC, et al. Lack of association between intussusception and oral polio vaccine in Cuban children. Eur J Epidemiol. 17:2001;783-787
9. Melton L. Lifesaving vaccine caught in an ethical minefield. Lancet. 356:2000;318
10. Weijer C. The future of research into rotavirus vaccine. BMJ. 321:2000;525-526
11. Murphy BR, Morens DM, Simonsen L, Chanock RM, La Montagne JR, Kapikian AZ. Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis. 187:2003;1301-1308
12. Murphy TV, Smith PJ, Gargiullo PM, Schwartz B. The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions. J Infect Dis. 187:2003;1309-1313
13. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 344:2001;564-572
14. Kramarz P, France EK, Destefano F, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J. 20:2001;410-416
15. Simonsen L, Morens D, Elixhauser A, Gerber M, Van Raden M, Blackwelder W. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet. 358:2001;1224-1229
16. Cherry JD. Pertussis and the vaccine controversy. In: Sande MA, Root RK, eds. Contemporary issues in infectious diseases. New York: Churchill Livingstone, 1989; 8: 47-63.
17. Peter G, Myers MG. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics. 110:2002;e67
18. Staat MA, Roberts NE, Bernstein D, et al. Effectiveness of Rotashield in preventing severe rotavirus disease requiring hospitalization. Baltimore: Pediatric Academic Societies' Meeting, 2002.
19. Clark HF, Offit PA, Glass RI, Ward RL. Rotavirus vaccines. Plotkin SA, Orenstein WA. Vaccines. 4th edn :2004;1327-1345 Saunders, Philadelphia
20. WHO. Report from Consensus Workshop: Rotavirus vaccines for the immunization of children in developing countries. Geneva: World Health Organization, January 9-10, 1997: 24.
21. Bresee J, Glass RI, Ivanoff B, Gentsch J. Current status and future priorities for rotavirus vaccine development, evaluation, and implementation in developing countries. Vaccine. 17:1999;2207-2222
22. Parashar UD, Holman RC, Cummings KC, et al. Trends in intussusception-associated hospitalizations and deaths among US infants. Pediatrics. 106:2000;1413-1421
23. Vesikari T, Karvonen A, Espo M, Korhonen T, Delem A, Vos BD. Efficacy evaluation of an oral human rotavirus (HRV) vaccine in previously uninfected Finnish infants. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting: San Diego, 2002.
24. Clark HF, Burke CJ, Volkin DB, et al. Safety, immunogenicity, and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation. Pediatr Infect Dis J. 22:2003;914-920
25. Perez-Schael I, Salinas B, Linhares AC, et al. Protective efficacy of an oral human rotavirus (HRV) vaccine in Latin American infants. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting: San Diego, 2002.